bioMérieux expands infectious disease test offering with $60 million Argene buy
This article was originally published in Scrip
Executive Summary
Moving to flesh out its infectious disease testing portfolio, French diagnostics firm bioMérieux has acquired virology testing specialist Argene in a deal worth up to €42.5 million ($60.15 million).